ImmuCell shares plummet on Q3 sales drop and discounted private placement by Arlene Weintraub Tuesday, October 18, 2016 One year ago, Portland, ME-based ImmuCell was drowning in orders for First Defense, a drug that protects calves from scours. The order backlog will contribute to a 20% sales drop in the third quarter, the company revealed.
